Drug
Who makes lamotrigine extended-release?
5 companies list lamotrigine extended-release as a human prescription drug. Forms: tablet; tablet, film coated, extended release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing lamotrigine extended-release
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Camber Pharmaceuticals, Inc.United States | tablet, film coated, extended release | ANDAANDA213949 | 6 | 1 |
| Yiling Pharmaceutical LtdChina | tablet, film coated, extended release | ANDAANDA213949 | 6 | 1 |
| Par Health USA, LLCIndia | tablet | ANDAANDA201791 | 3 | 5 |
| RemedyRepack, IncUnited States | tablet, film coated, extended release | ANDAANDA213949 | 2 | 1 |
| Proficient Rx LPUnited States | tablet, film coated, extended release | ANDAANDA213949 | 1 | 1 |
Enquiry
Common questions
- Who makes lamotrigine extended-release?
- 5 companies list lamotrigine extended-release as a human prescription drug in the openFDA NDC Directory, led by Camber Pharmaceuticals, Inc., Yiling Pharmaceutical Ltd, Par Health USA, LLC, RemedyRepack, Inc, Proficient Rx LP. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic lamotrigine extended-release?
- 5 companies list lamotrigine extended-release under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.